- Home
- ARVN vs MTRX Comparison
ARVN vs MTRX Comparison
Compare ARVN & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- MTRX
- Stock Information
- Founded
- ARVN 2015
- MTRX 1984
- Country
- ARVN United States
- MTRX United States
- Employees
- ARVN N/A
- MTRX N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- MTRX Engineering & Construction
- Sector
- ARVN Health Care
- MTRX Consumer Discretionary
- Exchange
- ARVN Nasdaq
- MTRX Nasdaq
- Market Cap
- ARVN 456.2M
- MTRX 405.6M
- IPO Year
- ARVN 2018
- MTRX 1990
- Fundamental
- Price
- ARVN $6.79
- MTRX $15.20
- Analyst Decision
- ARVN Buy
- MTRX Strong Buy
- Analyst Count
- ARVN 22
- MTRX 1
- Target Price
- ARVN $20.21
- MTRX $20.00
- AVG Volume (30 Days)
- ARVN 2.1M
- MTRX 133.0K
- Earning Date
- ARVN 08-06-2025
- MTRX 09-08-2025
- Dividend Yield
- ARVN N/A
- MTRX N/A
- EPS Growth
- ARVN N/A
- MTRX N/A
- EPS
- ARVN N/A
- MTRX N/A
- Revenue
- ARVN $372,800,000.00
- MTRX $742,408,000.00
- Revenue This Year
- ARVN $7.57
- MTRX $9.98
- Revenue Next Year
- ARVN N/A
- MTRX $20.42
- P/E Ratio
- ARVN N/A
- MTRX N/A
- Revenue Growth
- ARVN 299.57
- MTRX N/A
- 52 Week Low
- ARVN $5.90
- MTRX $8.92
- 52 Week High
- ARVN $29.61
- MTRX $16.11
- Technical
- Relative Strength Index (RSI)
- ARVN 41.59
- MTRX 59.19
- Support Level
- ARVN $6.06
- MTRX $14.63
- Resistance Level
- ARVN $7.83
- MTRX $15.17
- Average True Range (ATR)
- ARVN 0.40
- MTRX 0.49
- MACD
- ARVN -0.11
- MTRX -0.07
- Stochastic Oscillator
- ARVN 34.93
- MTRX 52.60
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About MTRX Matrix Service Company
Matrix Service Co is an engineering and construction provider for large industrial projects, primarily in the oil and gas, power, petrochemical, industrial, mining, and minerals markets. It offers engineering, fabrication, construction, and maintenance services, operating across three segments namely Utility and Power Infrastructure; Process and Industrial Facilities; and Storage and Terminal Solutions.